Related Experiment Video
Updated: Jul 16, 2025
08:41
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
1.2K
Chronic Liver Disease - What's New?
Ezyana Effandie1, Girish L Gupte2
1Liver Unit (Including Small Bowel Transplantation), Birmingham Women's and Children's Hospital, Steelhouse Lane, Birmingham, B4 6NH, UK.
Indian Journal of Pediatrics
|September 22, 2023
Summary
Chronic liver disease (CLD) management is evolving, focusing on halting progression and improving outcomes. Newer strategies, including gut microbiome modulation, offer hope for reducing morbidity and mortality in CLD patients.
Area of Science:
- Hepatology
- Gastroenterology
- Microbiology
Background:
- Chronic liver disease (CLD) affects over a billion people globally, posing a significant public health challenge.
- Disease progression is typically slow but variable, leading to end-stage liver disease.
- Emerging research highlights the gut microbiome's role in liver disease pathogenesis.
Purpose of the Study:
- To review recent advancements in CLD management.
- To explore novel therapeutic concepts and modalities for preventing CLD progression.
- To discuss the potential of targeting the gut microbiome in CLD treatment.
Main Methods:
- Review of current literature on CLD management.
- Analysis of recent findings in metabolomics and molecular technologies.
- Exploration of the gut-liver axis and its implications.
Main Results:
- Non-invasive monitoring tests show promise but require pediatric validation.
- Gut dysbiosis is increasingly recognized as a contributor to liver diseases.
- Modifying the gut microbiome presents a future therapeutic avenue for CLD.
Conclusions:
- Newer management strategies aim to halt CLD progression and prevent end-stage disease.
- Understanding the gut-liver axis is crucial for developing innovative CLD treatments.
- Future research should focus on validating non-invasive tests and microbiome-based therapies.
More Related Videos
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
108
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
108
01:24Chronic Pancreatitis I: Introduction
106
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
106
01:26Diseases of the Liver and Gallbladder
614
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
614
01:17Chronic Bowel Disorders: Introduction
474
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
474
01:25Chronic Kidney Disease I: Introduction
20
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
20
01:28Chronic Kidney Disease III: Interprofessional Care
28
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
28